학술논문
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
Document Type
Article
Author
Source
In: Molecular Pharmaceutics . (Molecular Pharmaceutics, 4 December 2023, 20(12):6213-6225)
Subject
Language
English
ISSN
15438392
15438384
15438384